By a News Reporter-Staff News Editor at Life Science Weekly -- Current study results on Health and Medicine have been published. According to news reporting out of West Bengal, India, by NewsRx editors, research stated, "Chitosan is a natural polysaccharide that has attracted significant scientific interest during the last two decades and chitosan based nanodrug delivery systems seem to be a hopeful and viable strategy for improving disease treatment. This study aims to evaluate the potency of the polymer based nanochloroquine in application for attenuation of Plasmodium berghei infection in Swiss mice and effectiveness against the parasite induced oxidative stress and deoxyribo nucleic acid (DNA) damage in lymphocytes."
Our news journalists obtained a quote from the research from Vidyasagar University, "Nanoparticle was prepared by ionotropic gelation between chitosan and sodium tripolyphosphate. The chloroquine was treated by the actual drug content of effective nanochloroquine and the nanodrug was charged with its effective dose for fifteen days, after successive infection development in Swiss mice. Gimsa staining of thin smear and flow cytometry analysis was pursued to reveal the parasitemia. Different oxidative markers, inflammatory markers, antioxidant enzymes level and also lymphocytic deoxyribo nucleic acid damage study were performed. The present study reveals the potency of the nanodrug which has been found as more prospective than only chloroquine treatment to combat the parasite infection, oxidative stress as well as inflammation and DNA damage."
According to the news editors, the research concluded: "From the study, we conclude this nanodrug may be applicable as potent therapeutic agent than only chloroquine."
For more information on this research see: A novel chitosan based antimalarial drug delivery against Plasmodium berghei infection. Acta Tropica, 2013;128(3):494-503. (Elsevier - www.elsevier.com; Acta Tropica - www.elsevier.com/wps/product/cws_home/506043)
Our news journalists report that additional information may be obtained by contacting S. Tripathy, Immunology and Microbiology Laboratory, Dept. of Human Physiology with Community Health, Vidyasagar University, Midnapore 721 102, West Bengal, India. Additional authors for this research include S.K. Mahapatra, S. Chattopadhyay, S. Das, S.K. Dash, S. Majumder, P. Pramanik and S. Roy (see also Health and Medicine).
Keywords for this news article include: Asia, India, Treatment, West Bengal, Health and Medicine.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC